Adam Pearce
Creating an ecosystem for innovation in medtech
At this year’s EuroPCR course (14–17 May, Paris, France), Shifamed president and chief executiv...
Alain Cribier remembered by heavyweights of TAVI
Michael Reardon and Lars Søndergaard pay tribute to the life and legacy of Alain Cribier—the pio...
SCAI statement seeks to guide physician operators and facilities on renal denervation use
The Society for Cardiovascular Angiography & Interventions’ (SCAI’s) position statement on ...
Latest-generation DCBs “change thinking” on treatment of coronary artery disease
Interventional cardiologists need to have a range of approaches and devices in their toolbox to t...
EuroPCR 2023: FAST-TAVI II highlights benefits of reducing length of stay after TAVI procedures
Implementation of a dedicated training programme allowed hospitals to increase the number of pa...
EuroPCR 2023: Pandemic cuts short EURO SHOCK trial, but results show promise for ECMO in cardiogenic shock patients
Enrolment in the EURO SHOCK trial was curtailed due to the COVID-19 pandemic, but the results o...
One-year real-world data “promising” for transcatheter tricuspid repair
One-year insights from the bRIGHT registry, detailing real-world results of tricuspid transcath...
HOSPITAVI elucidates underlying causes of rehospitalisations among TAVI patients
A single-centre retrospective study of rehospitalisation after transcatheter aortic valve impla...
TAVI pioneers discuss the past, present and future of transcatheter therapy
As transcatheter aortic valve implantation (TAVI) moves beyond its 20-year milestone, two pione...
TAVI will continue to grow, says pioneer of the procedure
Transcatheter aortic valve implantation (TAVI) will continue to spread across the globe as more...
AI holds “huge potential” for cardiology
The potential to utilise artificial intelligence (AI) or machine learning in cardiology is “huge”,...
New consensus statement will take into account latest clinical trial evidence on renal denervation
A new consensus statement—in development from the European Society of Cardiology (ESC) and the ...
EuroPCR 2022: “Clear need” for transcatheter options for tricuspid regurgitation
“At the moment, tricuspid is the valve where most things are happening,” says Hendrik Treede (U...
EuroPCR 2022: Robotic PCI changes the cath lab environment
Robotic-assisted percutaneous coronary intervention (PCI) has the potential to offer a raft of ...
EuroPCR 2022: CLASP TR among the trials to watch in the tricuspid space
Transcatheter tricuspid valve repair potentially offers a “less risky” option for patients with...
EuroPCR 2022: Lifetime management is an important question for the evolution of TAVI
Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolution of transcatheter...
EuroPCR 2022: Sham controlled trials have “revitalised” interest in renal denervation
“Renal denervation has travelled a very storied path over the last 10–15 years,” David Kandzari...
“Encouraging” early results for TEER seen in bRIGHT registry
The first analysis of findings from the bRIGHT registry, detailing real-world results of t...
“No red flags” for ticagrelor monotherapy according to stent type
George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent trial, presented at the...
ESC 2021: One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI
Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News about the latest findin...
ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial,...
Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR
John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...
EuroPCR 2021: Elective coronary revascularisation leads to “significant and robust reduction” of cardiac mortality compared with medical therapy alone
Eliano Navarese (Bydgoszcz, Poland) talks to Cardiovascular News about a large-scale meta-analy...
ACC 2021: Long-term blood pressure control the “holy grail” for renal denervation in patients with resistant hypertension
Ajay Kirtane (New York, USA) talks to Cardiovascular News about the RADIANCE-HTN TRIO trial whi...
CRT 2021: Biodegradable polymer sirolimus-eluting stent shows ‘promising’ results in STEMI patients
Thomas Pilgrim (Bern, Switerland) details two-year results from the BIOSTEMI randomised trial, whi...
NACMI registry offers insights into STEMI trends among COVID-19 patients
Tim Henry (Cincinnati, USA) talks to Cardiovascular News about the initial findings from the Nor...
Roxana Mehran on managing ischaemic benefit vs. bleeding harm in HBR patients (A three-part series)
Please NOTE: This video is ONLY available to watch in selected countries and geographies
PROGRESS PVL: One-year safety and performance outcomes for the ACURATE neo Aortic Valve System
NOTE: This video is ONLY available to watch in selected countries and geographies
Won-K...
TCT Connect 2020: Online interventional education in the COVID-19 age
Ahead of the first virtual edition of the Transcatheter Cardiovascular Therapeutics (TCT) meetin...
Study shows LAAO reduces major bleeding and mortality compared with NOACs in high-risk AF patients
Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score...
